May 16, 2011 By

Are New Diabetes Medications Worth the Money?

(I don’t think so, and here’s why.) The FDA just announced its approval of linagliptin (Tradjenta), a new diabetes medication developed by Eli Lilly and Company and Boehringer Inglheim. Linagliptin is the third drug to be approved in the class of medications commonly known as gliptins (scientifically known as dipeptidyl peptidase-4 (DPP-4) inhibitors) which block [...]

May 6, 2011 By

Endocrinologists Take a Backward Step in the Treatment of Hyperthyroidism

When I became an endocrinologist in 1981 I was truly excited about the field. At that time it seemed that the science of endocrinology was expanding rapidly and new discoveries were on the horizon particularly in regards to the way hormones effect the brain, mood and the immune system. Was I ever wrong! It’s thirty [...]

© 1998-2012 Metabolink, Inc. All rights reserved. Please read the Terms of Service and our Privacy Policy. Please send your feedback, comments and suggestions as well as marketing inquiries to marketing@metabolism.com. * From time to time advertising on our web pages provided by third parties may appear to offer hormone therapy without a prescription. It is beyond our control that such advertising is displayed. Metabolism.com deplores this type of advertising and is doing whatever possible to eliminate it. If you have a complaint we encourage you to address it to the company associated with the ad. Receiving treatment with growth hormone or testosterone without a prescription from a licensed professional is illegal, as is receiving treatment with these hormones for the sole purpose of enhancing athletic performance. Physicians who prescribe growth hormone or testosterone without performing a proper examination and history, and without provision for appropriate follow-up care, are breaking the law. We at metabolism.com continue to support an open and complete discussion of the use of these hormones for medical therapy.
x
GET DR. PEPPER'S BOOK